首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1460166

自體輸血設備市場 - 按產品、應用、最終用途 - 全球預測，2024 年 - 2032 年

Autotransfusion Devices Market - By Product, Application, End-use - Global Forecast, 2024 - 2032

出版日期: 2024年02月26日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在手術數量不斷增加和新產品不斷開發的推動下，自體輸血設備市場規模預計在 2024 年至 2032 年間以 6.2% 的CAGR擴大。

隨著全球外科手術數量的不斷增加，特別是在骨科、心臟和創傷手術中，對自體輸血設備的需求正在顯著增加。不斷進步的技術推動了創新自體輸血設備的開發，這些設備具有改進的功能，例如增強的過濾系統、緊湊的設計和方便用戶使用的介面。例如，2024 年 2 月，ProCell Surgical 的海綿血回收裝置獲得了 CE 標誌許可，這是一種改進醫院術中自體輸血 (IAT) 系統的專利設備。

最近，醫療保健系統也分配資金用於改善手術結果和減少輸血相關併發症。據印度國家衛生醫院聯合會稱，醫療保健部門主張將醫療保健支出增加至 GDP 的 2.5%。此外，對病患安全和資源高效利用的日益關注將進一步推動市場成長。

自體輸血設備產業分為產品、應用、最終用途和地區。

從產品來看，2024年至2032年消耗品及配件領域的市場規模預計將達到5.9%的成長率。最近，採血袋、過濾器、管道裝置和抽吸罐在自體輸血過程中發揮著至關重要的作用。需要輸血的手術數量不斷增加，加上自體輸血技術的進步，增加了對高品質耗材和配件的需求。醫院和外科中心依靠這些產品在手術過程中實現高效、安全的血液回收和回輸。此外，對減少輸血相關併發症和改善患者治療結果的高度重視進一步推動了先進耗材的採用。

在應用方面，骨科手術領域的自體輸血設備產業在2023年產生了可觀的收入，預計2024年至2032年的CAGR為6.6%。骨科手術，如關節置換和脊椎手術，由於輸血的原因，通常需要輸血。嚴重失血的可能性。自體輸血裝置對於收集、過濾和回輸患者的血液至關重要，同時減少同種異體輸血的需求和相關風險。由於人口老化和運動傷害的增加，對骨科手術的需求不斷成長，對高效血液管理解決方案的需求預計將保持穩定。

從地區來看，由於慢性病盛行率上升、手術數量增加以及醫療基礎設施改善，亞太地區自體輸血設備產業預計在 2024 年至 2032 年期間CAGR為 7.1%。中國、印度和日本等國的骨科、心臟和創傷手術激增，對自體輸血設備產生了巨大的需求。此外，人口老化以及人們對血液安全和輸血風險的認知不斷增強，正在推動區域市場的成長。

產業生態系統分析
產業影響力
- 成長動力
  - 外科手術數量不斷增加
  - 自體輸血裝置的技術進步
  - 對微創外科手術的需求不斷成長
- 產業陷阱與挑戰
  - 自體輸血系統相關的高成本
  - 併發症和感染的風險
成長潛力分析
監管環境
技術景觀
波特的分析
PESTEL分析
報銷場景
未來市場趨勢
缺口分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品分類，2018 年 - 2032 年

主要趨勢
自體輸血系統
- 術中自體輸血系統
- 術後自體輸血系統
- 雙模式自體輸血系統
耗材及配件

第 6 章：市場估計與預測：按應用分類，2018 年 - 2032 年

主要趨勢
心血管手術
骨科手術
器官移植
一般外科
其他應用

第 7 章：市場估計與預測：按最終用途，2018 - 2032 年

主要趨勢
醫院
門診手術中心
其他最終用戶

第 8 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Atrium Medical Corporation
Becton, Dickinson and Company
Beijing ZKSK Technology Co., Ltd.
Braile Biomédica
Fresenius SE & Co. KGaA
Gen World Medical Devices
Haemonetics Corporation
LivaNova, Inc.
Medtronic plc
Redax
Teleflex Incorporated

簡介目錄

Product Code: 8266

Autotransfusion Devices Market size is poised to expand at 6.2% CAGR between 2024 and 2032, propelled by the rising number of surgeries and continuous new product developments.

With the growing number of surgical procedures globally, particularly in orthopedics, cardiac, and trauma surgeries, the demand for autotransfusion devices is significantly rising. Rising technology advancements are leading to the development of innovative autotransfusion devices with improved features, such as enhanced filtration systems, compact designs, and user-friendly interfaces. For instance, in February 2024, ProCell Surgical received CE-marked clearance for its Sponge Blood Recovery Unit, a patented device that improves intraoperative autotransfusion (IAT) systems in hospitals.

Of late, healthcare systems are also allocating funds towards improving surgical outcomes and reducing transfusion-related complications. According to the National Health-Hospital Federation of India, the healthcare sector is advocating for an increase in healthcare expenditures to 2.5% of GDP. Moreover, the growing focus on patient safety and efficient resource utilization will further boost the market growth.

The autotransfusion devices industry is segmented into product, application, end-use, and region.

Based on product, the market size from the consumables & accessories segment is projected to record 5.9% growth rate from 2024-2032. Of late, blood collection bags, filters, tubing sets, and suction canisters are playing a crucial role in autotransfusion procedures. The rising number of surgeries requiring blood transfusions coupled with advancements in autotransfusion technology are boosting the demand for high-quality consumables and accessories. Hospitals and surgical centers rely on these products for efficient and safe blood recovery and reinfusion during procedures. Additionally, the strong emphasis on reducing transfusion-related complications and improving patient outcomes is further propelling the adoption of advanced consumables.

In terms of application, the autotransfusion devices industry from the orthopedic surgeries segment generated considerable revenue in 2023 and is estimated to witness 6.6% CAGR between 2024 and 2032. Orthopedic surgeries, such as joint replacements and spinal procedures, often require blood transfusions due to the potential for significant blood loss. Autotransfusion devices are essential in collecting, filtering, and reinfusing a patient's blood while reducing the need for allogeneic transfusions and associated risks. With the rising demand for orthopedic procedures due to an aging population and increasing sports injuries, the need for efficient blood management solutions is expected to remain steady.

Regionally, the Asia Pacific autotransfusion devices industry is set to exhibit 7.1% CAGR during 2024-2032 owing to the rising prevalence of chronic diseases, increasing number of surgeries, and improving healthcare infrastructure. Countries, such as China, India, and Japan are witnessing a surge in orthopedic, cardiac, and trauma surgeries, creating a substantial demand for autotransfusion devices. Additionally, the presence of an aging population and growing awareness about blood safety and transfusion risks are fueling the regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data sources
- 1.5.1 Primary
- 1.5.2 Secondary
  - 1.5.2.1 Paid sources
  - 1.5.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising number in surgical procedures
  - 3.2.1.2 Technological advancements in autotransfusion devices
  - 3.2.1.3 Growing demand for minimally invasive surgical procedures
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost associated with autotransfusion systems
  - 3.2.2.2 Risk of complications and infections
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis
3.8 Reimbursement scenario
3.9 Future market trends
3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Autotransfusion systems
- 5.2.1 Intraoperative autotransfusion systems
- 5.2.2 Post-operative autotransfusion systems
- 5.2.3 Dual-mode autotransfusion systems
5.3 Consumables & accessories

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Cardiovascular surgeries
6.3 Orthopedic surgeries
6.4 Organ transplantation
6.5 General surgery
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa